Mitogen-independent DNA synthesis by fetal rat hepatocytes in primary culture. 1993

T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
Department of Pediatrics, Rhode Island Hospital, Providence 02903.

We have identified conditions under which late gestation fetal rat hepatocytes in primary culture proliferate in the absence of serum, polypeptide growth factors, or insulin. Fetal hepatocytes, cultured in defined minimal essential medium (MEM) with hydrocortisone, synthesized DNA within the first 6 h after plating and for up to 72 h. Rates of thymidine incorporation into DNA by fetal hepatocytes exceeded peak rates seen with adult rat hepatocytes. The latter were quiescent following isolation, with DNA synthesis only occurring after 48 h exposure to insulin plus epidermal growth factor. Although they exhibited a high rate of DNA synthesis, the fetal hepatocytes retained sensitivity to added mitogens; DNA synthesis was stimulated three- to fourfold by subnanomolar concentrations of TGF-alpha. Fetal hepatocytes also were sensitive to the growth inhibitory effects of TGF-beta at concentrations below 10 pM. Finally, ontogenic changes in serum- and mitogen-independent fetal hepatocyte growth were observed, with declining rates of DNA synthesis as term approached. We speculate that the ability of fetal rat hepatocytes to synthesize DNA independent of added serum or mitogens may coincide with a proliferative in vivo phenotype.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016212 Transforming Growth Factor beta A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins. Bone-Derived Transforming Growth Factor,Platelet Transforming Growth Factor,TGF-beta,Milk Growth Factor,TGFbeta,Bone Derived Transforming Growth Factor,Factor, Milk Growth,Growth Factor, Milk

Related Publications

T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
February 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
December 1986, Experimental cell research,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
October 1980, Biochemical and biophysical research communications,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
February 1993, American journal of obstetrics and gynecology,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
January 1985, Endocrinology,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
May 1988, Journal of biochemistry,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
April 1984, Mutation research,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
January 2015, Bioscience, biotechnology, and biochemistry,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
May 1993, Biochemical and biophysical research communications,
T R Curran, and R I Bahner, and W Oh, and P A Gruppuso
November 1990, Mutation research,
Copied contents to your clipboard!